These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16684603)

  • 21. A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment.
    Mandel J; Bertrand V; Lehert P; Attarian S; Magy L; Micallef J; Chumakov I; Scart-Grès C; Guedj M; Cohen D
    Orphanet J Rare Dis; 2015 Jun; 10():74. PubMed ID: 26070802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4th Workshop of the European CMT-Consortium--62nd ENMC International Workshop: rare forms of Charcot-Marie-Tooth disease and related disorders 16-18 October 1998, Soestduinen, The Netherlands.
    Neuromuscul Disord; 1999 Jun; 9(4):279-87. PubMed ID: 10399758
    [No Abstract]   [Full Text] [Related]  

  • 23. Extended treatment of childhood Charcot-Marie-Tooth disease with high-dose ascorbic acid.
    Burns J; Ouvrier RA; Yiu EM; Ryan MM
    J Peripher Nerv Syst; 2011 Sep; 16(3):272-4. PubMed ID: 22003943
    [No Abstract]   [Full Text] [Related]  

  • 24. 71st ENMC International Workshop, 6th workshop of the European Charcot-Marie-Tooth disease consortium: hereditary recurrent focal neuropathies, 24-25 September 1999, Soestduinen, the Netherlands.
    Stögbauer F; Timmerman V; Van Broeckhoven C
    Neuromuscul Disord; 2000 Oct; 10(7):518-24. PubMed ID: 10996785
    [No Abstract]   [Full Text] [Related]  

  • 25. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
    Attarian S; Vallat JM; Magy L; Funalot B; Gonnaud PM; Lacour A; Péréon Y; Dubourg O; Pouget J; Micallef J; Franques J; Lefebvre MN; Ghorab K; Al-Moussawi M; Tiffreau V; Preudhomme M; Magot A; Leclair-Visonneau L; Stojkovic T; Bossi L; Lehert P; Gilbert W; Bertrand V; Mandel J; Milet A; Hajj R; Boudiaf L; Scart-Grès C; Nabirotchkin S; Guedj M; Chumakov I; Cohen D
    Orphanet J Rare Dis; 2014 Dec; 9():199. PubMed ID: 25519680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands.
    Merkies IS; Lauria G
    Neuromuscul Disord; 2006 Feb; 16(2):149-56. PubMed ID: 16431105
    [No Abstract]   [Full Text] [Related]  

  • 27. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.
    Hoogendijk JE; Amato AA; Lecky BR; Choy EH; Lundberg IE; Rose MR; Vencovsky J; de Visser M; Hughes RA
    Neuromuscul Disord; 2004 May; 14(5):337-45. PubMed ID: 15099594
    [No Abstract]   [Full Text] [Related]  

  • 28. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotrophin-3 therapy for Charcot-Marie-Tooth disease type 1A.
    Pleasure DE; Chance PF
    Neurology; 2005 Sep; 65(5):662-3. PubMed ID: 16157894
    [No Abstract]   [Full Text] [Related]  

  • 30. 145th ENMC International Workshop: planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD), 22-24th October 2006, Naarden, The Netherlands.
    Bushby K; Griggs R;
    Neuromuscul Disord; 2007 May; 17(5):423-8. PubMed ID: 17433676
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD; Sayed R; Garg M; Patil VA
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charcot-Marie-Tooth Disease Type 1A: Influence of Body Mass Index on Nerve Conduction Studies and on the Charcot-Marie-Tooth Examination Score.
    Jerath NU; Shy ME
    J Clin Neurophysiol; 2017 Nov; 34(6):508-511. PubMed ID: 28914656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charcot-Marie-Tooth disease type 1A: a family study with microsatellites.
    Qu Y; Carpenter NJ; Whetsell L; Smith SP; Say B
    J Okla State Med Assoc; 1996 Nov; 89(11):395-9. PubMed ID: 8972170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.
    Chao HC; Chou CT; Lee YC; Lin KP
    J Neurol Sci; 2015 Nov; 358(1-2):213-20. PubMed ID: 26349404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit.
    Pentao L; Wise CA; Chinault AC; Patel PI; Lupski JR
    Nat Genet; 1992 Dec; 2(4):292-300. PubMed ID: 1303282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A.
    Valentijn LJ; Bolhuis PA; Zorn I; Hoogendijk JE; van den Bosch N; Hensels GW; Stanton VP; Housman DE; Fischbeck KH; Ross DA
    Nat Genet; 1992 Jun; 1(3):166-70. PubMed ID: 1303229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 160th ENMC International Workshop (First ENMC practical care workshop) Exercise training in patients with muscle diseases: 20-22 June 2008, Naarden, The Netherlands.
    Vissing J; van Engelen BG
    Neuromuscul Disord; 2013 Feb; 23(2):182-7. PubMed ID: 23010306
    [No Abstract]   [Full Text] [Related]  

  • 38. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic testing practices for Charcot-Marie-Tooth type 1A disease.
    Tousignant R; Trepanier A; Shy ME; Siskind CE
    Muscle Nerve; 2014 Apr; 49(4):478-82. PubMed ID: 23963961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral nerve ultrasound in pediatric Charcot-Marie-Tooth disease type 1A.
    Yiu EM; Brockley CR; Lee KJ; Carroll K; de Valle K; Kennedy R; Rao P; Delatycki MB; Ryan MM
    Neurology; 2015 Feb; 84(6):569-74. PubMed ID: 25576636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.